The emerging need for connected, digital patient healthcare solutions has been accelerated by the healthcare workforce crisis – and improved options for scalable patient monitoring and data analytics have provided opportunities for the MedTech industry to jump in. In this episode, Jen is joined by Vynamic Director Andrew Sgarlato and Executive and Head of Healthcare …
On this week’s Trending News EU episode, Jack, Gemma, and Adrien share their insights from the recent Reuters Pharma 2023 conference held in Barcelona including the latest developments on Digital Health (1.51), Medical Affairs (3.50), Patient Engagement (7.11), and the perspectives from pharma leaders who attended Vynamic’s roundtable on patient initiative impact measurement (10.06) Podcast …
In this episode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including the judicial activity surrounding Mifepristone, a medical abortion drug, and the recent announcement of Kaiser’s acquisition of Geisinger to launch Risant Health. Podcast Tags: healthcare, healthcare news, health plans, life sciences, health policy, public health, mergers and acquisitions, FDA Source Links: …
DEI & You – Overcoming Data Biases to Advance Health Equity
April 27, 2023
A lack of clinical and epidemiological data for women, racial, and ethnic groups can contribute to diagnostic uncertainty, lower rates of clinical development for conditions most impacting these communities, and enduring disparities in health. In this episode, Jen is joined by Inizio’s Global Head of Diversity, Equity, & Inclusion, Stef Christmas, and special guest Soo …
In this episode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including Medicare Part D impacts from the Inflation Reduction Act, Novo Nordisk’s cuts to insulin prices, and the PBM Transparency Act of 2023. Podcast Tags: healthcare, healthcare news, health plans, life sciences, health policy, public health, Medicare, drug prices, PBMs Source Links: …
In this week’s Trending News EU episode, Jack, Ollie, and Will discuss a few recent newsworthy items on UK Life Sciences policy including what the latest spring budget means for Life Sciences (1.00), future pricing of branded medicines in the UK and differences with other countries (6.10), and how Life Sciences policy is working to …
Life Sciences, Health Systems, and Healthcare Tech: Working Together to Deliver Better Patient Outcomes
What if there was a digital tool that could close the loop between patient and provider, using data to improve diagnosis and treatment? Read how Vynamic addressed that question for a Life Sciences client by providing the leadership to make this concept a reality.
Establishing an Agile Commercial Innovation Hub for a Big Pharma That Wants to Operate More Like Healthcare Tech
A global Life Sciences company wanted to reinvent its commercial business model and disrupt the overall healthcare industry by operating more like a nimble biotech. To do so, the company engaged with Vynamic to develop an innovation capability that would allow it to run agile experiments and quickly learn from both the successes and failures while identifying potential solutions. Read how Vynamic established the value proposition, framework, and team structure to enable this innovative capability, while also providing the overall program monitoring and control.
Market Access Capability Analysis & Process Mapping for a Cell and Gene Therapy Biotech
A pre-commercial Cell and Gene Therapy client was preparing for the launch of its first product. Read how the newly formed Market Access team contacted Vynamic to assist with strategic planning and process development to support an innovative, outcomes-driven approach for value based contracting arrangements.
